IMPORTANT SAFETY INFORMATION
Do not take AZILECT® (rasagiline tablets) if you are taking meperidine as it could result in a serious reaction such as coma or death. Also, do not take AZILECT with tramadol, methadone, propoxyphene, dextromethorphan, St. John’s wort, or cyclobenzaprine. You also should not take AZILECT with other monoamine oxidase inhibitors (MAOIs), as it could result in an unsafe rise in blood pressure. Read More Important Safety Information
Parkinson's disease is a chronic, progressive disorder in which dopamine levels in your brain decline over time. Dopamine is the chemical messenger in your brain partly responsible for controlling movement and coordination in your body. It is used to send messages to your muscles to make them move properly.
In Parkinson's disease, the nerve cells that produce dopamine are damaged and unable to produce enough dopamine for normal movement. This decline of dopamine causes a variety of symptoms and problems with movement.
Parkinson's disease is progressive, which means symptoms may get worse as time goes by.
Approximately 1 million people in the United States have Parkinson's disease. Most people with Parkinson's are diagnosed when they are in their 60s, but estimates suggest that up to 15% of people with Parkinson's may have an early onset form of the disease, meaning they are diagnosed before the age of 40.
The chances of developing PD increase with age, and the disease affects slightly more men than women.
Although great progress has been made in understanding the disease, its cause is still unknown. It is thought that a combination of environmental and genetic factors contribute to the development of Parkinson's.
There are many effective therapies for Parkinson's disease today, and new medications and approaches are continually under development.
Many people find that, with the help of therapy, they can continue to work and enjoy the activities they love for many years after diagnosis.
AZILECT® (rasagiline tablets) is indicated for the treatment of Parkinson’s disease (PD).